Literature DB >> 23055885

Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?

Peter Gal1.   

Abstract

Entities:  

Year:  2009        PMID： 23055885      PMCID： PMC3461996          DOI： 10.5863/1551-6776-14.1.4

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN： 1551-6776


× No keyword cloud information.
  43 in total

1.  Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity.

Authors:  Nancy Chorne; Carol Leonard; Robert Piecuch; Ronald I Clyman
Journal:  Pediatrics       Date:  2007-06       Impact factor: 7.124

Review 2.  Patent ductus arteriosus: lack of evidence for common treatments.

Authors:  Carl L Bose; Matthew M Laughon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-11       Impact factor: 5.747

3.  Evidence for active closure of patent ductus arteriosus in very preterm infants.

Authors:  David B Knight; Matthew M Laughon
Journal:  J Pediatr       Date:  2008-03       Impact factor: 4.406

4.  Indomethacin and retinopathy of prematurity: the hidden paradox.

Authors:  Cathy Hammerman
Journal:  J Pediatr       Date:  2008-10       Impact factor: 4.406

5.  Oral ibuprofen for patent ductus arteriosus closure in preterm infants: does high osmolality matter?

Authors:  Luis Pereira-da-Silva; Ana Pita; Daniel Virella; Micaela Serelha
Journal:  Am J Perinatol       Date:  2008-05       Impact factor: 1.862

6.  Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit.

Authors:  K Herrman; C Bose; K Lewis; M Laughon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-05-01       Impact factor: 5.747

7.  Ibuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration?

Authors:  Cathy Hammerman; Irena Shchors; Stefan Jacobson; Michael S Schimmel; Ruben Bromiker; Michael Kaplan; Amiram Nir
Journal:  Pediatr Res       Date:  2008-09       Impact factor: 3.756

8.  Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus.

Authors:  Ling Yi Chang; Donald McCurnin; Bradley Yoder; Phillip W Shaul; Ronald I Clyman
Journal:  Pediatr Res       Date:  2008-03       Impact factor: 3.756

9.  Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial.

Authors:  Priya Jegatheesan; Vlad Ianus; Basharat Buchh; Grace Yoon; Nancy Chorne; Audrey Ewig; Emil Lin; Scott Fields; Anita Moon-Grady; Terri Tacy; Jay Milstein; Michael Schreiber; James Padbury; Ronald Clyman
Journal:  J Pediatr       Date:  2008-03-19       Impact factor: 4.406

10.  An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.

Authors:  Déborah Hirt; Bart Van Overmeire; Jean-Marc Treluyer; Jean-Paul Langhendries; Arnaud Marguglio; Mark J Eisinger; Paul Schepens; Saïk Urien
Journal:  Br J Clin Pharmacol       Date:  2008-02-27       Impact factor: 4.335
View more
  2 in total

1.  Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.

Authors:  Christopher McPherson; Peter Gal; J Laurence Ransom; Rita Q Carlos; Mary Ann V T Dimaguila; McCrae Smith; Christie Davonzo; John E Wimmer
Journal:  Pediatr Cardiol       Date:  2010-01-10       Impact factor: 1.655

2.  Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation.

Authors:  Jonathan L Slaughter; Clifford L Cua; Jennifer L Notestine; Brian K Rivera; Laura Marzec; Erinn M Hade; Nathalie L Maitre; Mark A Klebanoff; Megan Ilgenfritz; Vi T Le; Dennis J Lewandowski; Carl H Backes
Journal:  BMC Pediatr       Date:  2019-09-13       Impact factor: 2.125
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.